The Duke Human Vaccine Institute (DHVI) is pleased to announce that Matthew Kelly, MD, MPH, has joined DHVI as an affiliate faculty member.
On Thursday, November 9, 2023, Kevin Saunders, PhD, was honored with the 2023 Emerging Leader Award from the Duke Medical Alumni Association during a special dinner during Medical Alumni Weekend.
Six individuals and one team were honored with Distinguished Awards from the Duke Medical Alumni Association. The special dinner celebration took place at the Washington Duke Inn.
Clinical Immunization Safety Assessment Project Receives Contract from CDC to Continue Vaccine Safety Monitoring
The Duke Human Vaccine Institute (DHVI) successfully recompeted for a five-year, indefinite delivery/indefinite quantity (IDIQ) contract from the Centers for Disease Control and Prevention (CDC) Immunization Safety Office to serve as one of eight medical research centers for the Clinical Immunization Safety Assessment Project (CISA). The contract will allow DHVI to provide
The Duke Human Vaccine Institute (DHVI) is pleased to announce that Susanna Naggie, MD, MHS, has joined DHVI as an affiliate faculty member.
The Duke Human Vaccine Institute is pleased to announce that Dr. Chen-Hao Yeh has been promoted to the faculty position of Assistant Professor in the Department of Medicine at Duke, effective March 1, 2023.
The Duke Human Vaccine Institute is pleased to announce that Dr. Kevin O. Saunders has been promoted to Associate Professor in Surgery (tenure) effective July 1, 2022.
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the Duke Human Vaccine Institute - Immunology Virology Quality Assessment Center’s (DHVI-IVQAC) Biorepository based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. This biorepository accreditation covers the biorepository of Peripheral Blood Mononuclear cells (PBMCs) General Specimen Processing, Long Term Storage, and Distribution.